ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

GHRS Company Profile and Key Details

NASDAQ : GHRS

GH Research PLC

$9.17

0.07+0.77%

At Close 4:00 PM

58.75

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

GH Research PLC (GHRS) stock surged +0.77%, trading at $9.17 on NASDAQ, up from the previous close of $9.10. The stock opened at $9.01, fluctuating between $8.71 and $9.49 in the recent session.

Stock Snapshot

9.1

Prev. Close

9.01

Open

568.8M

Market Cap

62.03M

Number of Shares

8.71

Day Low

9.49

Day High

-12.23

P/E Ratio

65.2%

Free Float in %

-0.75

EPS (TTM)

4.21

Book Value

-0.64

Cash Flow per Share

97.79K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 21, 2025	9.01	9.53	8.66	9.17	101.29K
Apr 17, 2025	8.73	9.18	8.73	9.10	190.76K
Apr 16, 2025	8.85	9.36	8.51	8.70	132.56K
Apr 15, 2025	9.04	9.28	8.95	8.99	211.78K
Apr 14, 2025	9.11	9.20	8.87	9.09	145.12K
Apr 11, 2025	8.66	9.05	8.45	9.00	108.39K
Apr 10, 2025	8.88	9.12	8.22	8.66	102.63K
Apr 09, 2025	8.83	9.38	7.98	9.10	163.39K
Apr 08, 2025	9.74	9.84	8.90	8.97	108.75K
Apr 07, 2025	9.52	10.02	8.93	9.32	728.88K
Apr 04, 2025	9.65	10.14	8.78	10.09	261.49K
Apr 03, 2025	10.11	10.33	9.77	9.90	206.92K
Apr 02, 2025	10.50	10.99	10.04	10.40	280.67K
Apr 01, 2025	10.99	11.06	10.41	10.76	292.16K
Mar 31, 2025	10.78	11.28	10.60	11.03	123.62K
Mar 28, 2025	12.04	12.20	10.87	11.06	125.81K
Mar 27, 2025	11.90	13.21	11.90	12.25	208.61K
Mar 26, 2025	12.37	12.56	11.95	12.06	157.8K
Mar 25, 2025	13.13	13.13	12.45	12.53	227.62K
Mar 24, 2025	12.50	13.13	12.50	12.88	232.51K

Contact Details

Dublin, D02 NX43

Ireland

Website: https://www.ghres.comContact: 353 143 78443

About Company

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an injectable 5-MeO-DMT product candidate; and GH003, an intranasal 5-MeO-DMT product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.

Frequently Asked Questions

What is the current GH Research PLC (GHRS) stock price?

GH Research PLC (NASDAQ: GHRS) stock price is $9.17 in the last trading session. During the trading session, GHRS stock reached the peak price of $9.49 while $8.71 was the lowest point it dropped to. The percentage change in GHRS stock occurred in the recent session was 0.77% while the dollar amount for the price change in GHRS stock was $0.07.

GHRS's industry and sector of operation?

The NASDAQ listed GHRS is part of Biotechnology industry that operates in the broader Healthcare sector. GH Research PLC designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of GHRS?

Ms. Julie Ryan F.C.A.
Vice President of Fin.
Dr. Theis Terwey M.D.
Co-Founder & Chief Executive Officer
Mr. Aaron Cameron
Vice President of Technical Devel. & Operational Planning
Mr. Theis Terwey M.D.
Co-Founder & Chief Executive Officer
Ms. Julie Ryan A.C.A.
Vice President of Fin.
Mr. Florian Schonharting M.Sc. (Econ)
Co-Founder & Non-Executive Chairman
Mr. Magnus Halle
Co-Founder & MD of Ireland

How GHRS did perform over past 52-week?

GHRS's closing price is 52.83% higher than its 52-week low of $6.00 where as its distance from 52-week high of $20.50 is -55.27%.

How many employees does GHRS have?

Number of GHRS employees currently stands at 50.

Link for GHRS official website?

Official Website of GHRS is: https://www.ghres.com

How do I contact GHRS?

GHRS could be contacted at phone 353 143 78443 and can also be accessed through its website. GHRS operates from 28 Baggot Street Lower, Dublin, D02 NX43, Ireland.

How many shares of GHRS are traded daily?

GHRS stock volume for the day was 97.79K shares. The average number of GHRS shares traded daily for last 3 months was 525.22K.

What is the market cap of GHRS currently?

The market value of GHRS currently stands at $568.80M with its latest stock price at $9.17 and 62.03M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

News

Investing Crypto Market Business US Stocks

Useful Links

Screener Market Data Insider Transactions Upgrades & Downgrades 52 Week Highs & Lows Unusual Volume Dividend Calendar Earnings Calendar

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	50
Beta	0.85
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology